/index.php?option=com_iwpfile&file=/dir_05/he2005_1121.pdf

/index.php?option=com_iwpfile&file=/dir_05/he2005_1120.pdf

/index.php?option=com_iwpfile&file=/dir_05/he2005_1119.pdf

/index.php?option=com_iwpfile&file=/dir_05/he2005_1118.pdf

FDA Letter Attachment A Attachment B

WNV Guidance FDA Notice

References: Blood Products Advisory Committee meeting October 22, 2004 -- Transcript Guidance for Industry: Revised Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected


/index.php?option=com_iwpfile&file=/dir_05/he2005_1114.pdf

/index.php?option=com_iwpfile&file=/dir_05/he2005_1115.pdf

Draft Strategic Plan Draft Program Standards Advanced Copy Of Notice Of Availability USDA Press Release

/index.php?option=com_iwpfile&file=/dir_05/he2005_1112.pdf

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.